Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Extensive preclinical and clinical data on moxifloxacin presented at ICAAC

Oct. 14, 1997

New results reported for Glaxo Wellcome's anti-HCMV agent at ICAAC

Oct. 14, 1997

MycoTox awarded four SBIR awards for antifungal drug discovery

Oct. 14, 1997

NIH grant to support development of CytRx's Protox

Oct. 13, 1997

GM-237354: a new antifungal sordarin derivative from Glaxo Wellcome

Oct. 13, 1997

Cubist and Merck expand antibiotic collaboration

Oct. 10, 1997

Mechanism of action of oxazolidinones elucidated

Oct. 9, 1997

CFC-222: a promising therapeutic for bacterial infections

Oct. 9, 1997

Significant research efforts center on new ketolide at Hoechst Marion Roussel

Oct. 9, 1997

New carbapenem derivatives described by Sankyo

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.